Global Intravascular Ultrasound (IVUS) Equipment Market Strategic Research Report

Scope of the Report

The global Intravascular Ultrasound (IVUS) Equipment market size is predicted to grow from US$ 420 million in 2025 to US$ 594 million in 2032; it is expected to grow at a CAGR of 5.2% from 2026 to 2032.

IVUS is a catheter-based endovascular imaging device: a catheter equipped with a miniature ultrasound transducer is inserted into the blood vessel lumen to provide real-time imaging of the lesion segment and output cross-sectional images of the vessel during retraction. This allows observation of the lumen area, vessel wall layering, plaque morphology, calcification extent, stent apposition and expansion. In terms of product form, IVUS typically consists of a main unit/control console, signal processing and image reconstruction unit, retraction/drive mechanism (some products are mechanically rotating), display and measurement software, and a disposable imaging catheter. Some next-generation products further integrate with FFR/iFR, NIRS, or OCT for multimodal fusion. In application, IVUS is primarily used for coronary PCI and peripheral vascular interventions, its value lying in improving the accuracy of lesion assessment, device selection, stent optimization, and postoperative confirmation.

The global intravascular ultrasound (IVUS) equipment market is defined by a core landscape where "foreign-funded industry leaders dominate the fundamental market, Chinese manufacturers accelerate their catch-up, and multimodal technology integration shapes new growth drivers". As the gold-standard device for precision coronary intervention therapy, IVUS has seen a continuous rise in its penetration rate in percutaneous coronary intervention (PCI) procedures worldwide. Penetration exceeds 70% in mature markets across Europe, the United States, and Japan, and has also been gradually increasing in tertiary hospitals in China in recent years.In terms of market competition, Boston Scientific and Philips have long held a dominant position in both the global and China's IVUS markets. Boston Scientific’s iLab series IVUS imaging system, paired with its OptiCross high-definition imaging catheters, is the mainstream installed model in catheterization laboratories (cath labs) of top tertiary hospitals in China. Philips ranks second with its EPIQ CVx cardiovascular ultrasound platform and supporting EagleEye series catheters, underpinned by its leading multimodal image fusion capabilities. Meanwhile, other foreign brands including NIPRO and ACIST Medical Systems also hold a certain market share with their strengths in niche application scenarios, together forming a well-established foreign-funded monopoly structure in the market.

The integrated fusion of IVUS and optical coherence tomography (OCT) is currently the most definitive high-growth track in the IVUS equipment industry, as well as the core breakthrough point for Chinese manufacturers to achieve overtaking on the curve. According to research data, the market is expected to reach USD 91.28 million by 2031, posting a robust Compound Annual Growth Rate (CAGR) of 19.36% during the 2025-2031 forecast period.In this track, Canada-based Conavi Medical Inc stands as the global pioneer. Its Novasight Hybrid system is the world’s first single-catheter integrated IVUS-OCT system to obtain dual marketing clearance from the U.S. Food and Drug Administration (FDA) and China’s National Medical Products Administration (NMPA), securing the top position in overseas market share in 2025. Japan’s Terumo also rapidly entered the market in 2025 with its OPUSWAVE system, leveraging the group’s full industrial chain layout in the coronary intervention sector.Chinese manufacturers, for their part, have achieved large-scale breakthroughs. Panovision launched the S1 system, the first IVUS-OCT integrated system approved in China. Grand Pharmaceutical’s NOVASYNC system, Horimed Technology Co., Ltd’s HSD100 system, and InnerMedical Co., Ltd’s H8i system have also successively obtained NMPA marketing approval and quickly entered top-tier tertiary hospitals in China, forming a cluster advantage for Chinese manufacturers in the multimodal track.

In the process of China's substitution in the single-modality IVUS sector, Chinese manufacturers have likewise made core technological breakthroughs and are gradually breaking the foreign-funded monopoly. For instance, Sonoscape Medical Corp’s V-reader series ultra-wideband IVUS system has established itself as the leader in China's single-modality IVUS market. MicroPort Medical and other enterprises have also completed the commercialization of IVUS equipment relying on their full industrial chain layout in the cardiovascular intervention field, with the core performance of their products reaching the mainstream international level.From the perspective of market drivers, coronary intervention guidelines in China and overseas have upgraded IVUS-guided complex PCI to a Class I recommendation. Coupled with the rising incidence of coronary artery disease driven by global population aging and the continuous growth in PCI procedure volumes, the long-term market demand for IVUS equipment is highly certain.Looking ahead, industry competition will shift from a pure focus on hardware performance to the rivalry of end-to-end solutions integrating "IVUS imaging + Fractional Flow Reserve (FFR) functional assessment + interventional therapy". With their first-mover advantage in the multimodal integration track and localized service capabilities in China, Chinese manufacturers are expected to continuously gain market share and reshape the competitive landscape of the global IVUS equipment market.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Intravascular Ultrasound (IVUS) Equipment market?

What factors are driving Intravascular Ultrasound (IVUS) Equipment market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Intravascular Ultrasound (IVUS) Equipment market opportunities vary by end market size?

How does Intravascular Ultrasound (IVUS) Equipment break out by Type, by Application?

This report presents a comprehensive overview of the global Intravascular Ultrasound (IVUS) Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Mobile IVUS System
• Wall-mounted IVUS System

Segment by Technology

• Basic Diagnostic IVUS System
• IVUS - FFR System
• IVUS - OCT System

Segment by Application

• Public Hospitals
• Private Hospitals

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Intravascular Ultrasound (IVUS) Equipment market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Public Hospitals, Private Hospitals evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact